Canada’s largest pharmacy chain is being sold to a group that has a long history of financial misconduct.

The Canadian Pharmacists Association announced on Thursday that its board of directors would vote on the sale of Rite Aid to a consortium led by investment firm Teneo.

The deal, which would represent the second-largest Canadian pharmacy chain in terms of sales, would be announced in a press release.

The group has a history of ethical lapses and conflicts of interest, including paying off former employees who had complained about poor treatment at Rite Aid, and also using sham business deals to make money for itself.

A representative for the group told ABC News that the group “will be working closely with its Board to ensure that all of the facts surrounding the transaction are fully disclosed, including the financial impact to the industry.”

The company’s current CEO, Paul Ehrlich, was a former vice president at Teneos investment firm.

He has been accused of wrongdoing in the past for allegedly failing to disclose the ties between Teneolos and a drug company he owned.

A spokesperson for the Canadian Pharmacy Association told ABCNews.com that the company will be working “closely with its board to ensure the full and complete facts surrounding this transaction are publicly disclosed.”